Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-27

Clinical Trial Update: Efficacy of Nigella Sativa (Nisatol®) in Women With Borderline Blood Pressure Values or a Non-Dipper Blood Pressure Phenotype [NA]

View source ↗

Summary

Clinical trial evaluating Nigella sativa (Nisatol) for blood pressure-related outcomes in women with borderline or non-dipper hypertension; recruitment has not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nisatol (Nigella sativa)

Snippet

Sponsor: Liaquat University of Medical & Health Sciences | Conditions: Prehypertension, Hypertension | NA | Status: NOT_YET_RECRUITING